Patient survival after renal transplantation in HCV and HBV infected patients needs more attention than other risk factors

Clinical Nephrology

Volumn 72, Issue 4, 2009, Pages 326-327

  Alavian, S M ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; LAMIVUDINE; VIRUS RNA;

HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY TRANSPLANTATION; LETTER; LIVER FAILURE; LIVER GRAFT REJECTION; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; SURVIVAL RATE;

EID: 70350370808     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp72326     Document Type: Letter

References (21)

1. Kliem V, Michel U, Burg M, Bock A, Chapman J, Dussol B et al. Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation. Clin Nephrol. 2009; 71: 423-429.
2. Druwe PM, Michielsen PP, Ramon AM, De Broe ME. Hepatitis C and nephrology. Nephrol Dial Transplant. 1994; 9: 230-237.
3. Moghaddam SM, Alavian SM, Kermani NA. Hepatitis C and renal transplantation: a review on historical aspects and current issues. Rev Med Virol. 2008; 18: 375-386.
4. Garcia-Bengoechea M, Emparanza JI, Sarriugarte A, Cortes A, Vega JL, Gonzalez F et al. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. Eur J Gastroenterol Hepatol. 1995; 7: 237-241.
5. Morin T, Pariente A, Cadranel JF, Denis J. Role of nosocomial hospital transmission in acute hepatitis C. J Hepatol. 2009; 50: 214; author reply.
6. Hosseini Moghaddam SM, Alavian SM, Rahnavardi M. Therapeutic aspects of hepatitis C in hemodialysis patients. Am J Nephrol. 2008; 29: 123-128.
7. Alavian SM, Hosseini-Moghaddam SM, Rahnavardi M. Hepatitis C among hemodialysis patients: a review on epidemiologic, diagnostic, and therapeutic features. Hepatitis Monthly. 2007; 7: 153-162.
8. Alavian SM, Hajarizadeh B, Einollahi B. Efficacy and safety of lamivudine for treatment of chronic hepatitis B in renal allograft recipients. Transplant Proc. 2003; 35: 2687-2678.
9. Khan LA, Khan SA. Prevalence of hepatitis B and C markers in patients on maintenance hemodialysis in Najran. Saudi Med J. 2001; 22: 641-642.
10. Weir MR, Kirkman RL, Strom TB, Tilney NL. Liver disease in recipients of long-surviving renal allografts. Kidney Int. 1985; 28: 839-844.
11. Fishman JA, Rubin RH, Koziel MJ, Periera BJG. Hepatitis C virus and organ transplantation. Transplantation. 1996; 62: 147-154.
12. Pereira BJ. Hepatitis C in organ transplantation: its significance and influence on transplantation policies. Curr Opin Nephrol Hypertens. 1993; 2: 912-922.
13. Pereira BJ. Renal transplantation in patients positive for hepatitis B or C (con). Transplant Proc. 1998; 30: 2070-2072.
14. Kokado Y, Takahara S, Ichimaru N, Toki K, Wang JD, Permpongkosol S et al. Clinical outcome of HCV infection after renal transplantation. Transplant Proc. 2000; 32: 1940-1943.
15. Stempel CA, Lake J, Kuo G, Vincenti F. Hepatitis C: Its prevalence in end-stage renal failure patients and clinical course after kidney transplantation. Transplantation 1993; 55: 273-276.
16. Natov SN. Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 1: hepatitis B virus). Transpl Infect Dis. 2002; 4: 124-131.
17. Einollahi B, Hajarizadeh B, Bakhtiari S, Lesan-Pezeshki M, Khatami MR, Noourbala MH et al. Pretransplant hepatitis C virus infection and its effect on the post-trans plant course of living renal allograft recipients. J Gastroenterol Hepatol. 2003; 18: 836-840.
18. Einollahi B, Pourfarziani V, Ahmadzad-Asl M, Lessan-Pezeshki M, Davoudi A, Nourbala MH et al. Iranian model of renal allograft transplantation in 3028 recipients: Survival and risk factors. Transplant Proc. 2007; 39: 907-910.
19. Fabrizi F, Takkouche B, Lunghi G, Dixit V, Messa P, Martin P. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies. J Viral Hepat. 2007; 14: 697-703.
20. Butt AA, Skanderson M, McGinnis KA, Ahuja T, Bryce CL, Barnato AE et al. Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis. J Viral Hepat. 2007; 14: 688-696.
21. Alavian SM. Hepatitis C, chronic renal failure, control is possible! Hepatitis Monthly. 2006; 6: 551-552.